Press release
Multidrug-Resistant Tuberculosis (MDR-TB) Market in 2034: Important Players Otsuka Pharmaceuticals and Johnson & Johnson (Bedaquiline)
Multidrug-Resistant Tuberculosis
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72907
The growing burden of MDR-TB, especially in Asia-Pacific, Africa, and Eastern Europe, has intensified global efforts to develop new drug regimens, rapid diagnostics, and treatment access programs. Pharmaceutical companies, non-profits, and global health organizations are collaborating to accelerate the fight against MDR-TB.
In 2024, the global MDR-TB market is valued at USD 1.42 billion and is projected to reach USD 2.63 billion by 2034, growing at a CAGR of 6.5%.
Market Overview
• Market Size 2024: USD 1.42 billion
• Forecast 2034: USD 2.63 billion
• CAGR (2025-2034): 6.5%
Key Drivers
• Rising global TB incidence, with MDR-TB cases increasing annually.
• WHO-supported initiatives and funding for TB eradication.
• Advancements in rapid molecular diagnostics.
• Pipeline of novel drugs and shorter MDR-TB regimens.
• Increased global awareness and government support for TB control.
Key Challenges
• High treatment costs and poor patient compliance.
• Severe side effects of current MDR-TB regimens.
• Growing risk of extensively drug-resistant TB (XDR-TB).
• Limited access to advanced treatments in low-income countries.
Leading Players
Johnson & Johnson (bedaquiline), Otsuka Pharmaceutical (delamanid), Pfizer, Novartis, Sanofi, Lupin Pharmaceuticals, Cipla, Viatris, Macleods Pharmaceuticals, and several regional generic drug manufacturers.
Segmentation Analysis
By Drug Class
• First-Line Drugs (limited efficacy in MDR-TB)
• Second-Line Drugs (fluoroquinolones, injectable agents)
• Novel MDR-TB Drugs (bedaquiline, delamanid, pretomanid)
• Combination Therapies
By Treatment Regimen
• Standard Long-Term MDR-TB Regimens
• Shorter All-Oral MDR-TB Regimens
• Novel Combination Therapy Regimens
By End User
• Hospitals
• Specialty TB Clinics
• Public Health Programs
• Research & Academic Institutes
Summary:
Novel all-oral regimens (including bedaquiline, pretomanid, and linezolid) are transforming MDR-TB treatment, offering shorter, safer, and more effective alternatives compared to traditional injectable-based therapies.
Explore Full Report here: https://exactitudeconsultancy.com/reports/72907/multidrug-resistant-tuberculosis-market
Regional Analysis
• North America
Advanced diagnostic infrastructure and access to novel MDR-TB therapies, but limited patient pool.
• Europe
Significant burden in Eastern Europe and Russia, with strong government-led TB control programs.
• Asia-Pacific
Largest and fastest-growing market, driven by high prevalence in India, China, Indonesia, and the Philippines. Strong support from WHO and government-funded TB programs.
• Middle East & Africa
High MDR-TB incidence with limited healthcare access. International aid programs drive treatment availability.
• Latin America
Brazil and Peru lead adoption, supported by global health funding for TB eradication.
Summary:
Asia-Pacific dominates in terms of disease burden and market share, while Africa and Latin America remain priority regions for international TB control programs.
Market Dynamics
Growth Drivers
1. Increasing global MDR-TB incidence and mortality rates.
2. Adoption of shorter all-oral MDR-TB regimens improving compliance.
3. Rising global health funding and government-backed TB initiatives.
4. Rapid adoption of GeneXpert and molecular diagnostics for early detection.
5. Growing role of generic manufacturers in expanding access.
Challenges
• Drug resistance progression toward XDR-TB.
• High cost of novel therapies in low-income countries.
• Limited healthcare infrastructure for effective treatment delivery.
• Side effects of MDR-TB medications reducing adherence.
Latest Trends
• Development of next-generation TB drugs targeting resistant strains.
• Expansion of fixed-dose combinations for simplified regimens.
• Integration of AI and digital health tools for treatment monitoring.
• Public-private partnerships for affordable global access.
• Expansion of global generic manufacturing to increase affordability.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72907
Competitor Analysis
Key Players
• Johnson & Johnson (bedaquiline)
• Otsuka Pharmaceutical (delamanid)
• Pfizer
• Novartis
• Sanofi
• Lupin Pharmaceuticals
• Cipla
• Viatris
• Macleods Pharmaceuticals
• Regional generic suppliers
Competitive Landscape
The market is moderately consolidated, with Johnson & Johnson and Otsuka leading with novel MDR-TB drugs. Generic manufacturers from India and Asia-Pacific play a critical role in improving affordability and expanding access. Partnerships with WHO, UNITAID, and Global Fund shape the competitive dynamics.
Conclusion
The MDR-TB market is a critical component of global healthcare, addressing a life-threatening public health challenge. Valued at USD 1.42 billion in 2024, it is projected to reach USD 2.63 billion by 2034, growing at a CAGR of 6.5%.
Future opportunities lie in shorter, safer all-oral regimens, generic manufacturing expansion, AI-based treatment monitoring, and next-generation drug development. Companies that focus on innovation, affordability, and global partnerships will play a decisive role in combating MDR-TB worldwide.
This report is also available in the following languages : Japanese (多剤耐性結核), Korean (다제내성 결핵), Chinese (耐多药结核病), French (Tuberculose multirésistante), German (Multiresistente Tuberkulose), and Italian (Tubercolosi multiresistente ai farmaci), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/72907/multidrug-resistant-tuberculosis-market#request-a-sample
Our More Reports:
Rehabilitation Robots Market
https://exactitudeconsultancy.com/reports/73437/rehabilitation-robots-market
Automated Suturing Devices Market
https://exactitudeconsultancy.com/reports/73438/automated-suturing-devices-market
Connected Drug Delivery Devices Market
https://exactitudeconsultancy.com/reports/73439/connected-drug-delivery-devices-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Multidrug-Resistant Tuberculosis (MDR-TB) Market in 2034: Important Players Otsuka Pharmaceuticals and Johnson & Johnson (Bedaquiline) here
News-ID: 4207174 • Views: …
More Releases from Exactitude Consultancy
Vacuum Insulated Pipe Market Projected to Reach USD 2.36 Billion by 2034
Introduction: A Market Built on Cryogenic Efficiency and Innovation
The global Vacuum Insulated Pipe (VIP) market is witnessing a steady surge driven by the expanding cryogenic industry, increased liquefied natural gas (LNG) trade, and rising demand for efficient liquid gas transportation systems. These specialized double-wall pipes, engineered with high vacuum insulation between inner and outer layers, have become indispensable in industries handling cryogenic fluids such as liquid nitrogen, oxygen, argon, and…
Solar PV Mounting Systems Market is Expected to Reach USD 31.7 Billion by 2034
Introduction: Powering the Next Decade of Solar Expansion
The Solar PV Mounting Systems Market is emerging as a crucial pillar in the clean energy revolution, enabling efficient, cost-effective, and durable installations of photovoltaic (PV) modules across rooftops, open fields, and floating structures. As the world accelerates toward carbon neutrality, the demand for robust, modular, and adaptable mounting systems has intensified across residential, commercial, and utility-scale solar projects.
Download Full PDF Sample Copy…
Tall Oil Fatty Acid Market projected to reach USD 2.21 billion by 2034
Introduction: A Sustainable Feedstock Powering the Future of Bio-based Chemicals
The Tall Oil Fatty Acid (TOFA) Market is gaining strong traction as industries increasingly shift toward renewable, sustainable, and bio-based chemical alternatives. Derived as a byproduct from the kraft pulping process of pine wood, TOFA has become a vital raw material in the production of alkyd resins, dimer acids, lubricants, coatings, and adhesives. Its unique composition-rich in oleic and linoleic acids-makes…
Lithium-Ion Battery Recycling Market Projected to Reach USD 27.3 Billion by 2034
Introduction: Powering the Circular Energy Transition
As the world accelerates toward electrification and clean energy, the demand for lithium-ion batteries has skyrocketed-fueling everything from electric vehicles (EVs) to smartphones and grid storage systems. However, this exponential growth brings with it an urgent environmental challenge: how to sustainably manage end-of-life batteries.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/25354
The Lithium-Ion Battery Recycling Market has emerged as a cornerstone of the global…
More Releases for Pharmaceutical
Metronidazole Market 2023 Latest Innovations and Outlook By Players - Hongyuan P …
The Metronidazole Market 2023 study focuses on a global evaluation of information from the most recent market developments. The purpose of MarketsandResearch.biz is to offer the company's customers a comprehensive market overview to formulate development plans.
Designing of the report is done with the help of infographics, charts, and graphs. The report initially analyzes the various segments of the global Metronidazole market in a brief manner, which includes product types, applications.…
Hyperthyroidism Treatment Market Analytical Overview and Future | Merck, Herbran …
The Hyperthyroidism Treatment market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with development…
Mevastatin Market Is Booming Worldwide |Zhejiang Hisun Pharmaceutical, Guangdong …
Global Mevastatin Market Size research report 2022 offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. This study provides information about the sales and revenue during the historic and forecasted period of (2022 to 2028). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for…
Global Specialty Pharmaceutical Market Driving Future Growth on Specialty Pharma …
Global Specialty Pharmaceutical Industry Synopsis:
The Specialty Pharmaceutical Market report provides a detailed analysis of this business space. The market is analyzed in terms of production as well as consumption. Based on the production aspect, the report includes particulars pertaining to the manufacturing processes of the product, alongside revenue and gross margins of the respective manufacturers.
The Global Specialty Pharmaceutical Market will reach xxx Million USD in 2020 with CAGR xx%…
Metronidazole Market to 2023 (+5% CAGR Expected) Top Player Profiles – Hongyua …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR
Scope of the Report:
This report focuses on the Metronidazole in global market, especially in…
Metronidazole Market by Top Key Participant Hongyuan Pharmaceutical, Yinhe Aarti …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Get Sample Copy of this Report @ https://www.researchbeam.com/global-metronidazole-2018-by-manufacturers-regions-type-and-application-forecast-to-2023-market/request-sample?utm_source=Anil
Scope of the Report:
This report focuses on the Metronidazole in global market, especially in North…
